Boehringer, Servier sign gevokizumab manufacturing agreement
18:51 EDT 6 Aug 2012 | Pharmaceutical Business Review
Boehringer Ingelheim has signed a manufacturing agreement with Servier and its partner XOMA to produce gevokizumab at its facility in Biberach, Germany, for Servier's commercial use.
Original Article: Boehringer, Servier sign gevokizumab manufacturing agreement
More From BioPortfolio on "Boehringer, Servier sign gevokizumab manufacturing agreement"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
